Drug Safety

Drug Safety

Risk Sciences International has significant experience managing drug safety to help related stakeholders ensure the health and well-being of the public.

RSI has experience in analyzing pharmacokinetics and pharmacodynamics of drugs including NOACs, drugs which promote sleep, statins and other medications. Risk analysis has included both men and women, as well as specific studies on the difference between adults, children, geriatric, and pregnancy using population PK, non-compartmental modeling, physiologically based pharmacokinetic (PBPK) modeling.